Profil

Cugnata Sarah

See author's contact details
Main Referenced Co-authors
Le Goff, Caroline  (3)
Cavalier, Etienne  (2)
Brevers Eric (1)
Delcour, Sandra  (1)
Gadisseur, Romy  (1)
Main Referenced Keywords
epidemiology (1); invasive candidiasis (1); resistance (1);
Main Referenced Disciplines
Laboratory medicine & medical technology (4)

Publications (total 4)

The most downloaded
56 downloads
Cugnata, S., Sacheli, R., Layios, N.* , & Hayette, M.-P.*. (19 June 2025). Species Distribution and Antifungal Susceptibility Patterns of Invasive Candidiasis in a Belgian Tertiary Center: A 7-Year Retrospective Analysis. Journal of Fungi, 11 (6), 465. doi:10.3390/jof11060465 https://hdl.handle.net/2268/333607

The most cited

3 citations (OpenAlex)

Cugnata, S., Sacheli, R., Layios, N.* , & Hayette, M.-P.*. (19 June 2025). Species Distribution and Antifungal Susceptibility Patterns of Invasive Candidiasis in a Belgian Tertiary Center: A 7-Year Retrospective Analysis. Journal of Fungi, 11 (6), 465. doi:10.3390/jof11060465 https://hdl.handle.net/2268/333607

Cugnata, S., Sacheli, R., Layios, N.* , & Hayette, M.-P.*. (19 June 2025). Species Distribution and Antifungal Susceptibility Patterns of Invasive Candidiasis in a Belgian Tertiary Center: A 7-Year Retrospective Analysis. Journal of Fungi, 11 (6), 465. doi:10.3390/jof11060465
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Cugnata, S., Gadisseur, R., DELCOUR, S., Cavalier, E., & Le Goff, C. (2023). COMPARISON OF HIGH-SENSITIVITY CARDIAC TROPONIN I BETWEEN SIEMENS POINT OF CARE ATELLICA VTLI AND ABBOTT ALINITY [Poster presentation]. Euromedlab 2023.
Peer reviewed

Le Goff, C., Ghahouo Guelasso Ange, Cugnata, S., Brevers Eric, Pincemail, J., Peeters Stephanie, & Cavalier, E. (18 November 2022). LIPOPRINT: A NEW TOOL FOR THE CARDIOVASCULAR RISK ASSESMENT? [Poster presentation]. RBSLM Symposium, Bruxelles, Belgium.

Le Goff, C., & Cugnata, S. (15 September 2022). Mesure des sous-classes des lipoprotéines LDL et HDL sur le Lipoprint : intérêt en clinique? [Paper presentation]. Formation continue de biologie clinique.

Contact ORBi